Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

NCT00257491 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension

NCT02177422 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Efficacy and Tolerability of Micardis®/Micardis® Plus in Patients With Hypertension

NCT02242357 ·Status: COMPLETED

PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN

NCT00274599 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients

NCT01108809 ·Status: COMPLETED

Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)

NCT02262637 ·Status: COMPLETED

An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension

NCT00904215 ·Status: COMPLETED

Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters

NCT00615108 ·Status: COMPLETED

Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension

NCT02242838 ·Status: COMPLETED

Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure

NCT02242864 ·Status: COMPLETED

Relative Bioavailability of Telmisartan and HCTZ in Two Experimental Formulations Compared to the Standard Formulation Telmisartan and HCTZ in Healthy Female and Male Subjects

NCT02262572 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension

NCT02242344 ·Status: COMPLETED ·Phase: PHASE2

Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients

NCT00863980 ·Status: TERMINATED ·Phase: NA

Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk Hypertensives

NCT00539487 ·Status: COMPLETED

Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension

NCT02177409 ·Status: COMPLETED ·Phase: PHASE3

Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM

NCT00274612 ·Status: COMPLETED ·Phase: PHASE4

Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension

NCT02183701 ·Status: COMPLETED ·Phase: PHASE3

Natriuretic Effect of Telmisartan Versus Placebo in Patients With Mild-to-Moderate Hypertension

NCT02176499 ·Status: COMPLETED ·Phase: PHASE3

J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation

NCT00659581 ·Status: COMPLETED

A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers

NCT05223101 ·Status: UNKNOWN ·Phase: PHASE1

An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice

NCT00982735 ·Status: COMPLETED

Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension

NCT00659607 ·Status: COMPLETED

Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial

NCT00147264 ·Status: COMPLETED ·Phase: PHASE3

Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension

NCT00281593 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension

NCT00133185 ·Status: COMPLETED ·Phase: PHASE3